AAAAAA
Results:
1-15
|
Results: 15
Authors:
Song, RXD
Mor, G
Naftolin, F
McPherson, RA
Song, J
Zhang, ZG
Yue, W
Wang, JP
Santen, RJ
Citation: Rxd. Song et al., Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17 beta-estradiol, J NAT CANC, 93(22), 2001, pp. 1714-1723
Authors:
Devanesan, P
Santen, RJ
Bocchinfuso, WP
Korach, KS
Rogan, EG
Cavalieri, E
Citation: P. Devanesan et al., Catechol estrogen metabolites and conjugates in mammary tumors and hyperplastic tissue from estrogen receptor-alpha knock-out (ERKO)/Wnt-1 mice: implications for initiation of mammary tumors, CARCINOGENE, 22(9), 2001, pp. 1573-1576
Authors:
Santen, RJ
Pinkerton, J
McCartney, C
Petroni, GR
Citation: Rj. Santen et al., Clinical review 121 - Risk of breast cancer with progestins in combinationwith estrogen as hormone replacement therapy, J CLIN END, 86(1), 2001, pp. 16-23
Authors:
Santen, RJ
Petroni, GR
Fisch, MJ
Myers, CE
Theodorescu, D
Cohen, RB
Citation: Rj. Santen et al., Use of the aromatase inhibitor anastrozole in the treatment of patients with advanced prostate carcinoma, CANCER, 92(8), 2001, pp. 2095-2101
Authors:
Jeng, MH
Yue, W
Eischeid, A
Wang, JP
Santen, RJ
Citation: Mh. Jeng et al., Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells, BREAST CANC, 62(3), 2000, pp. 167-175
Authors:
Pauley, RJ
Santner, SJ
Tait, LR
Bright, RK
Santen, RJ
Citation: Rj. Pauley et al., Regulated CYP19 aromatase transcription in breast stromal fibroblasts, J CLIN END, 85(2), 2000, pp. 837-846
Authors:
Shim, WS
Conaway, M
Masamura, S
Yue, W
Wang, JP
Kumar, R
Santen, RJ
Citation: Ws. Shim et al., Estradiol hypersensitivity and mitogen-activated protein kinase expressionin long-term estrogen deprived human breast cancer cells in vivo, ENDOCRINOL, 141(1), 2000, pp. 396-405
Authors:
Yue, M
Santen, RJ
Wang, JP
Hamilton, CJ
Demers, LM
Citation: M. Yue et al., Aromatase within the breast, ENDOCR-R CA, 6(2), 1999, pp. 157-164
Authors:
Santen, RJ
Yue, W
Naftolin, F
Mor, G
Berstein, L
Citation: Rj. Santen et al., The potential of aromatase inhibitors in breast cancer prevention, ENDOCR-R CA, 6(2), 1999, pp. 235-243
Authors:
Santen, RJ
Harvey, HA
Citation: Rj. Santen et Ha. Harvey, Use of aromatase inhibitors in breast carcinoma, ENDOCR-R CA, 6(1), 1999, pp. 75-92
Authors:
Shim, WS
DiRenzo, J
DeCaprio, JA
Santen, RJ
Brown, M
Jeng, MH
Citation: Ws. Shim et al., Segregation of steroid receptor coactivator-1 from steroid receptors in mammary epithelium, P NAS US, 96(1), 1999, pp. 208-213
Authors:
Santen, RJ
Petroni, GR
Citation: Rj. Santen et Gr. Petroni, Relative versus attributable risk of breast cancer from estrogen replacement therapy, J CLIN END, 84(6), 1999, pp. 1875-1881
Authors:
Costa, LAM
Kopreski, MS
Demers, LM
Chinchilli, VM
Santen, RJ
Harvey, HA
Lipton, A
Citation: Lam. Costa et al., Effect of the potent aromatase inhibitor fadrozole hydrochloride (CGS 16949A) in postmenopausal women with breast carcinoma, CANCER, 85(1), 1999, pp. 100-103
Authors:
Tekmal, RR
Santen, RJ
Citation: Rr. Tekmal et Rj. Santen, Local estrogen production - Is aromatase an oncogene?, CONT ENDOC, 11, 1999, pp. 79-92
Authors:
Mor, G
Yue, W
Santen, RJ
Gutierrez, L
Eliza, M
Berstein, LM
Harada, N
Wang, JP
Lysiak, J
Diano, S
Naftolin, F
Citation: G. Mor et al., Macrophages, estrogen and the microenvironment of breast cancer, J STEROID B, 67(5-6), 1998, pp. 403-411
Risultati:
1-15
|